Clinical trials data
N-Back Task in sleep trials: 51 registered studies
Every registered sleep and sleep disorders study on ClinicalTrials.gov that names the N-Back Task in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered sleep and sleep disorders studies name it in an outcome measure
- 51
- Name it in a primary outcome, 39%
- 20 of 51
Tests named in the same studies
- 1
Psychomotor Vigilance Task27 studies, 17 as a primary outcome
- 2
Symbol Coding14 studies, 10 as a primary outcome
- 3
Balloon Risk14 studies, 5 as a primary outcome
- 4
Go/No-Go Task12 studies, 1 as a primary outcome
- 5
Digit Span Test10 studies, 2 as a primary outcome
- 6
Trail Making Test7 studies, 1 as a primary outcome
- 7
Card Sorting Test (Berg)7 studies, 0 as a primary outcome
- 8
Task Switching Test6 studies, 2 as a primary outcome
- 9
Delay Discounting4 studies, 3 as a primary outcome
- 10
Verbal Learning4 studies, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 2 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 2 | 1 |
| 2016 | 2 | 2 |
| 2017 | 4 | 1 |
| 2018 | 6 | 3 |
| 2019 | 4 | 2 |
| 2020 | 1 | 0 |
| 2021 | 5 | 3 |
| 2022 | 6 | 2 |
| 2023 | 6 | 2 |
| 2024 | 3 | 1 |
| 2025 | 4 | 2 |
| 2026 | 2 | 0 |
Phases and study sizes
By phase
- Phase 13 studies, 1 as a primary outcome
- Phase 22 studies, 1 as a primary outcome
- Phase 31 studies, 0 as a primary outcome
- Phase 42 studies, 1 as a primary outcome
- Not applicable41 studies, 17 as a primary outcome
- Observational2 studies, 0 as a primary outcome
Participants per study
- Not applicable58 median, 35 to 105
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 40 | 58 | 35 to 105 |
When sleep trials measure it
Latest time point of each outcome
- Within a day6 outcomes, 2 as a primary outcome
- Up to 4 weeks21 outcomes, 12 as a primary outcome
- 1 to 3 months8 outcomes, 2 as a primary outcome
- 3 to 6 months9 outcomes, 0 as a primary outcome
- 6 to 12 months1 outcomes, 0 as a primary outcome
- No duration given6 outcomes, 4 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
45 of the 51 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting9 studies, 3 as a primary outcome
- Completed32 studies, 15 as a primary outcome
- Stopped early2 studies, 1 as a primary outcome
- Status unknown8 studies, 1 as a primary outcome
What they test
- Behavioral21 studies, 6 as a primary outcome
- Drug12 studies, 3 as a primary outcome
- Device7 studies, 4 as a primary outcome
- Dietary supplement3 studies, 1 as a primary outcome
- Radiation3 studies, 2 as a primary outcome
- Other9 studies, 4 as a primary outcome
- None given1 studies, 0 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States12 studies, 5 as a primary outcome
- Hong Kong9 studies, 1 as a primary outcome
- Singapore6 studies, 5 as a primary outcome
- Switzerland6 studies, 1 as a primary outcome
- China4 studies, 0 as a primary outcome
- France4 studies, 3 as a primary outcome
- Sweden3 studies, 2 as a primary outcome
- Canada1 studies, 0 as a primary outcome
- Germany1 studies, 1 as a primary outcome
- Taiwan1 studies, 0 as a primary outcome
- United Kingdom1 studies, 0 as a primary outcome
11 countries in all. A study with sites in several counts in each; 3 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed sleep and sleep disorders studies that name the N-Back Task: 17 of 32, 53%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed sleep and sleep disorders studies that name the N-Back Task | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 1, 3% | 776, 10% |
| Results on ClinicalTrials.gov only | 2, 6% | 1,139, 14% |
| A results paper only | 14, 44% | 1,711, 22% |
| Neither | 15, 47% | 4,327, 54% |
The 51 studies
51 studies match. 20 name the N-Back Task in a primary outcome. Median size 56 participants. Median time to the primary outcome: 2 weeks.
Loading 51 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 2 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 2 | 1 |
| 2016 | 2 | 2 |
| 2017 | 4 | 1 |
| 2018 | 6 | 3 |
| 2019 | 4 | 2 |
| 2020 | 1 | 0 |
| 2021 | 5 | 3 |
| 2022 | 6 | 2 |
| 2023 | 6 | 2 |
| 2024 | 3 | 1 |
| 2025 | 4 | 2 |
| 2026 | 2 | 0 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 5, other 46. Interventional 49, observational 2.
As a primary outcomeSecondary or other outcomeThe N-Back Task
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07903896 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Sleep and sleep disorders, Anxiety, PTSD and OCD | Participants75 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07830056 | Start2025 | PhasePhase 4 | ConditionsSleep and sleep disorders | Participants33 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07695246 | Start2026 | PhaseNot applicable | ConditionsAging, frailty and exercise, Sleep and sleep disorders | Participants183 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07085754 | Start2025 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07084701 | Start2025 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06824415 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Sleep and sleep disorders | Participants55 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06307483 | Start2023 | PhaseObservational | ConditionsSleep and sleep disorders, Cardiovascular disease | Participants499 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06286774 | Start2024 | PhaseNot applicable | ConditionsSubstance use and addiction, Sleep and sleep disorders | Participants256 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06260254 | Start2024 | PhaseNot applicable | ConditionsObesity and diabetes, Sleep and sleep disorders | Participants23 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06054243 | Start2023 | PhaseNot applicable | ConditionsSleep and sleep disorders, Anxiety, PTSD and OCD | Participants137 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05956392 | Start2023 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants150 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05790161 | Start2023 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants54 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05764798 | Start2022 | PhasePhase 1 | ConditionsSleep and sleep disorders | Participants60 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05611619 | Start2023 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants45 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05485415 | Start2022 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants66 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05481424 | Start2022 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants20 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05409339 | Start2016 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants20 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05372900 | Start2022 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants43 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT05319262 | Start2022 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants12 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05270369 | Start2022 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants159 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05260801 | Start2024 | PhaseNot applicable | ConditionsSleep and sleep disorders | ParticipantsNot given | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT05232383 | Start2021 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants96 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05050812 | Start2021 | PhaseNot applicable | ConditionsMild cognitive impairment, Sleep and sleep disorders, Pain and fatigue | Participants8 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT04975360 | Start2019 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants32 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT04736017 | Start2021 | PhaseNot applicable | ConditionsMild cognitive impairment, Parkinson's disease, Sleep and sleep disorders | Participants48 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
Questions, answered from the data
How many sleep trials use the N-Back Task?
51 registered sleep and sleep disorders studies on ClinicalTrials.gov name it in an outcome measure, 20 of them in a primary outcome: 7% of the condition's 749 studies with a cognitive outcome, against 5% of all of them. It is the 8th most named test in sleep trials.
Which tests do sleep trials use with the N-Back Task?
The Psychomotor Vigilance Task (27 studies), Symbol Coding (14 studies) and Balloon Risk (14 studies).
When do sleep trials measure the N-Back Task?
Half of the primary outcomes that name the N-Back Task are measured within 2 weeks of the start, and the middle half from 2 days to 2 weeks. 16 primary outcomes give a duration.
How many completed sleep trials that use the N-Back Task have reported results?
17 of the 32 completed studies that name it, 53%, have reported results: 3 posted them on ClinicalTrials.gov, 15 have a results paper linked to the registry record, and 1 did both. The other 15 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts 1-Back Task and 2-Back Task as one test family, so this page counts their studies together.
Run the N-Back Task in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.